Osteoarthritis Market Expected To Be Valued US$ 11,618.6 Mn By 2025
Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide.
In order to cater
to the needs of the rapidly increasing geriatric population as well as the
female population – given that osteoarthritis prevails mostly among these
groups – the manufacturers of osteoarthritis drugs are focusing on research and
development to be able to develop better and reliable drugs.
As this disease is
not treatable, the market is an ever growing one. In this run, the leading
companies are also collaborating with other big companies in order to use their
formulas and production equipment.
For instance, in
September 2016, Pfizer Inc. completed the acquisition of Medivation, Inc., a
biopharmaceutical company focused on the development and commercialization of
medically innovative therapies to treat serious diseases that have limited
treatment options.
To Remain ‘Ahead’
Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/4458
In this regard, the
company also acquired the commercialization and development rights of the late
stage small molecules anti-infective business, mainly outside the U.S. from
AstraZeneca.
According to the
report, the global osteoarthritis treatment market is expected to register a CAGR of 4.8% from 2017 to 2025. In 2017, the
market was valued at US$ 7,969.7 Mn and
is expected to rise to a valuation of US$ 11,618.6 Mn by
the end of 2025.
Growing Geriatric
Population and Rising Prevalence of Disease to Trigger Adoption
The prevalence of
osteoarthritis is increasing across the globe and it is the major cause of
disability, especially among the ageing population.
Women are more
likely to be affected than men and the prevalence rate progresses with age.
Increasing awareness regarding the risk factors associated with osteoarthritis
(such as obesity) among the general population due to government action plans
to control the disease is expected to boost the growth of the osteoarthritis
treatment market.
However,
improvement in healthcare policies in various countries such as the U.S. has
resulted in enhanced affordability for various diagnostic and treatment
services, which in turn has increased the life expectancy of people. Other
dynamics such as the availability of alternative medicines are expected to
boost the growth of the market.
For Critical
Insights On The Osteoarthritis Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/4458
Company Profiles
·
Pfizer Inc.
·
Johnson & Johnson Services, Inc.
·
Novartis AG
·
GlaxoSmithKline plc.
·
Zimmer Biomet Holdings, Inc.
·
Stryker Corporation
·
Abbott Laboratories
·
Others.
For In-Depth
Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/4458
Non-availability of
Permanent Cure for Osteoarthritis to Restrict Market Growth
Presently, there is
no cure of osteoarthritis but the treatment is aimed to manage the symptoms.
Aspects such as lack of awareness regarding risk factors and symptoms of
osteoarthritis is expected to restrain the growth of the osteoarthritis
treatment market.
There is no simple
diagnosis available for osteoarthritis. Diagnosis is based on a variable
combination of patient-reported symptoms and imaging of the joint. Mostly x-ray
is used to diagnose osteoarthritis, but it often does not correlate with other
symptoms of osteoarthritis including joint pain.
About Us:
Persistence Market
Research is here to provide companies a one-stop solution with regards to
bettering customer experience. It does engage in gathering appropriate feedback
after getting through personalized customer interactions for adding value to
customers’ experience by acting as the “missing” link between “customer
relationships” and “business outcomes’. The best possible returns are assured
therein.
Contact Us:
Persistence Market
Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website –
https://www.persistencemarketresearch.com
Comments
Post a Comment